Insider Trading Activity For Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Randal J Kirk , Major Shareholder of Halozyme Therapeutics, Inc. (NASDAQ:HALO) reportedly Sold 53,505 shares of the company’s stock at an average price of 17.34 for a total transaction amount of $927,776.70 SEC Form
Recent Trading Activity for Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Shares of Halozyme Therapeutics, Inc. closed the previous trading session at 16.87 +0.00 0.00% with 17.170000076293945 shares trading hands.